The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486

Abstract Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. The alveolar subtype (ARMS) is clinically more aggressive, and characterized by an oncogenic fusion protein PAX3-FOXO1 that drives oncogenic cellular properties. Exosomes are small, secreted vesicles that affect para...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Farah Ghamloush, Sandra E. Ghayad, Ghina Rammal, Assil Fahs, Abeer J. Ayoub, Zeina Merabi, Mohamad Harajly, Hassan Zalzali, Raya Saab
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/48ff41dea4bf4d4aae9196741925086f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:48ff41dea4bf4d4aae9196741925086f
record_format dspace
spelling oai:doaj.org-article:48ff41dea4bf4d4aae9196741925086f2021-12-02T15:09:28ZThe PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-48610.1038/s41598-019-50592-42045-2322https://doaj.org/article/48ff41dea4bf4d4aae9196741925086f2019-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-50592-4https://doaj.org/toc/2045-2322Abstract Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. The alveolar subtype (ARMS) is clinically more aggressive, and characterized by an oncogenic fusion protein PAX3-FOXO1 that drives oncogenic cellular properties. Exosomes are small, secreted vesicles that affect paracrine signaling. We show that PAX3-FOXO1 transcript alters exosome content of C2C12 myoblasts, leading to pro-tumorigenic paracrine effects in recipient cells. Microarray analysis revealed alteration in miRNA content of exosomes, affecting cellular networks involved in cell metabolism, growth signaling, and cellular invasion. Overexpression and knockdown studies showed that miR-486-5p is an effector of PAX3-FOXO1, and mediates its paracrine effects in exosomes, including promoting recipient cell migration, invasion, and colony formation. Analysis of human RMS cells showed miR-486-5p is enriched in both cells and exosomes, and to a higher extent in ARMS subtypes. Analysis of human serum samples showed that miR-486-5p is enriched in exosomes of patients with RMS, and follow-up after chemotherapy showed decrease to control values. Our findings identify a novel role of both PAX3-FOXO1 and its downstream effector miR-486-5p in exosome-mediated oncogenic paracrine effects of RMS, and suggest its possible use as a biomarker.Farah GhamloushSandra E. GhayadGhina RammalAssil FahsAbeer J. AyoubZeina MerabiMohamad HarajlyHassan ZalzaliRaya SaabNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Farah Ghamloush
Sandra E. Ghayad
Ghina Rammal
Assil Fahs
Abeer J. Ayoub
Zeina Merabi
Mohamad Harajly
Hassan Zalzali
Raya Saab
The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486
description Abstract Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. The alveolar subtype (ARMS) is clinically more aggressive, and characterized by an oncogenic fusion protein PAX3-FOXO1 that drives oncogenic cellular properties. Exosomes are small, secreted vesicles that affect paracrine signaling. We show that PAX3-FOXO1 transcript alters exosome content of C2C12 myoblasts, leading to pro-tumorigenic paracrine effects in recipient cells. Microarray analysis revealed alteration in miRNA content of exosomes, affecting cellular networks involved in cell metabolism, growth signaling, and cellular invasion. Overexpression and knockdown studies showed that miR-486-5p is an effector of PAX3-FOXO1, and mediates its paracrine effects in exosomes, including promoting recipient cell migration, invasion, and colony formation. Analysis of human RMS cells showed miR-486-5p is enriched in both cells and exosomes, and to a higher extent in ARMS subtypes. Analysis of human serum samples showed that miR-486-5p is enriched in exosomes of patients with RMS, and follow-up after chemotherapy showed decrease to control values. Our findings identify a novel role of both PAX3-FOXO1 and its downstream effector miR-486-5p in exosome-mediated oncogenic paracrine effects of RMS, and suggest its possible use as a biomarker.
format article
author Farah Ghamloush
Sandra E. Ghayad
Ghina Rammal
Assil Fahs
Abeer J. Ayoub
Zeina Merabi
Mohamad Harajly
Hassan Zalzali
Raya Saab
author_facet Farah Ghamloush
Sandra E. Ghayad
Ghina Rammal
Assil Fahs
Abeer J. Ayoub
Zeina Merabi
Mohamad Harajly
Hassan Zalzali
Raya Saab
author_sort Farah Ghamloush
title The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486
title_short The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486
title_full The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486
title_fullStr The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486
title_full_unstemmed The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486
title_sort pax3-foxo1 oncogene alters exosome mirna content and leads to paracrine effects mediated by exosomal mir-486
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/48ff41dea4bf4d4aae9196741925086f
work_keys_str_mv AT farahghamloush thepax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT sandraeghayad thepax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT ghinarammal thepax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT assilfahs thepax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT abeerjayoub thepax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT zeinamerabi thepax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT mohamadharajly thepax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT hassanzalzali thepax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT rayasaab thepax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT farahghamloush pax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT sandraeghayad pax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT ghinarammal pax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT assilfahs pax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT abeerjayoub pax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT zeinamerabi pax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT mohamadharajly pax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT hassanzalzali pax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
AT rayasaab pax3foxo1oncogenealtersexosomemirnacontentandleadstoparacrineeffectsmediatedbyexosomalmir486
_version_ 1718387811928768512